MedPath
HSA Approval

LOSARTAN-TEVA FC TABLET 50MG

SIN16974P

LOSARTAN-TEVA FC TABLET 50MG

LOSARTAN-TEVA FC TABLET 50MG

March 22, 2024

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09CA01

losartan

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Teva Pharma, S.L.U.

Active Ingredients

Losartan potassium

50 mg

Losartan

Documents

Package Inserts

Losartan Teva FCT PI.pdf

Approved: March 22, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LOSARTAN-TEVA FC TABLET 50MG - HSA Approval | MedPath